Skip to Content

Join the 'Humatrope' group to help and get support from people like you.

Humatrope News

Childhood 'Growth' Tests Not Always Necessary

Posted 6 Oct 2017 by Drugs.com

FRIDAY, Oct. 6, 2017 – Just because a child isn't growing or developing exactly like his or her peers doesn't mean a host of medical tests are in order. In fact, five medical tests commonly ordered for children who are short, overweight or showing signs of early puberty aren't always necessary. And, that's particularly true if youngsters are otherwise healthy, according to the American Academy ...

Growth Hormone May Lower Odds of Fractures in Older Women

Posted 27 Aug 2015 by Drugs.com

THURSDAY, Aug. 27, 2015 – Older women with osteoporosis could get lasting benefits from a few years on growth hormone, a new, small trial suggests. Researchers found that when women with the bone-thinning disease took growth hormone for three years, their fracture risk was still reduced seven years later. Before entering the study, 56 percent of the women had suffered a bone break; over the ...

Short Boys Three Times More Likely to Get Growth Hormone: Study

Posted 16 Jun 2015 by Drugs.com

TUESDAY, June 16, 2015 – Short boys are much more likely than short girls to receive growth hormones, a new study finds. Researchers examined the medical records of more than 283,000 children and teens in the United States and found that short boys were up to three times more likely than short girls to receive recombinant human growth hormone treatment. Specifically, males accounted for 74 ...

Children Prescribed Growth Hormone May Face Stroke Risk Later: Study

Posted 13 Aug 2014 by Drugs.com

WEDNESDAY, Aug. 13, 2014 – Children who are prescribed human growth hormone may be at greater risk of a stroke in early adulthood than their peers are, a new study suggests. While the study raises important questions about the safety of human growth hormone treatments, the study's French researchers encouraged parents to discuss the pros and cons of treatment with their child's physician. "For ...

FDA Medwatch Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death

Posted 5 Aug 2011 by Drugs.com

[UPDATED 08/04/2011] FDA has determined that, at this time, the evidence regarding recombinant human growth hormone and increased risk of death is inconclusive. In its analysis of the SAGhE study, FDA identified a number of study design weaknesses that limit the interpretability of the study results. FDA also reviewed the medical literature, as well as reports from the Agency's Adverse Event ...

Ask a Question

Further Information

Related Condition Support Groups

Adult Human Growth Hormone Deficiency, Short Stature for Age, Pediatric Growth Hormone Deficiency, Prader-Willi Syndrome, Turner's Syndrome, Hypopituitarism, Idiopathic Short Stature

Humatrope Patient Information at Drugs.com